Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
As of today, Pfizer(PFE) shares are valued at $27.79. The company's market cap stands at 158.42B, with a P/E ratio of 37.24 and a dividend yield of 6.12%.
During the trading session on 2026-10-02, Pfizer(PFE) shares reached a daily high of $28.19 and a low of $27.44. At a current price of $27.79, the stock is +1.3% higher than the low and still -1.4% under the high.
Trading activity shows a volume of 34.91M, compared to an average daily volume of 34.98M.
The stock's 52-week range extends from a low of $23.62 to a high of $29.21.
The stock's 52-week range extends from a low of $23.62 to a high of $29.21.
PFE News
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has updated results from its TACTIVE-U Sub-Study C, a Phase 1b/2 trial...
As the global healthcare landscape shifts toward weight-loss treatments and chronic care, investors are weighing two giants. Should you invest in Novo Nordisk A...
Pfizer (PFE) presented results from two Phase 3 trials evaluating the efficacy and safety of LITFULO as a once-daily oral treatment across a wide range of disea...
Analyst ratings
61%
of 28 ratingsMore PFE News
If you've been looking for high-yield stocks, Pfizer (PFE -1.40%) may have crossed your radar screen. As shares of the pharma giant slipped over the past few ye...
After 100 days at the head of the Federal Reserve, Kevin Warsh gave a speech outlining the economic situation. While employment has been stable, which is positi...
Pfizer Inc. (NYSE:PFE) on Thursday presented detailed Phase 2 results for tilrekimig (PF-07275315) in adults with moderate-to-severe atopic dermatitis. The ong...
Pfizer (NYSE:PFE) reported Phase 2 data for tilrekimig, a trispecific antibody candidate, in moderate to severe atopic dermatitis. The study showed clinically...
Florida Attorney General James Uthmeier filed a lawsuit against Pfizer (PFE) and its CEO Dr. Albert Bourla. Uthmeier said via X: “Weeks ago we learned Fauci and...
Investing Treasury Yields Are Above 5%. These 4 Dividend Stocks Still Make the Cut A 5% Treasury yield raises the bar for every dividend stock in a retirement p...
Pfizer (PFE) presented detailed results from an ongoing Phase 2 study investigating tilrekimig in adults with moderate-to-severe atopic dermatitis. The study me...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.